27/02/2024
With the increasing presence of medicinal cannabis imports into the local market, Australian cultivators are calling for greater support to promote homegrown products.
Cann Group’s Cultivation Manager, Angus Murray, said Australian grown cannabis products are now at a level that is equal to, if not superior to, those that are arriving from overseas.
“Until recently, the industry faced challenges with local production and prestige. Now, with capacity on Australian shores, medicinal cannabis businesses must assess if imported material surpasses locally cultivated cannabis in niche fulfilment, quality, diversity and sustainability.
“Mapping the value stream, domestic cropping wins every time – it reduces supply-chain complexities, and fewer shipping disruptions give local producers a clear edge.
“Beyond just national pride, supporting good-quality local growers contributes to economic output, job creation, and transferable skills in the broader biotech, high-tech agriculture and pharmaceutical industry.”
